Literature DB >> 11295358

Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells.

D Sorescu1, M J Somers, B Lassègue, S Grant, D G Harrison, K K Griendling.   

Abstract

Endogenously produced reactive oxygen species are important for intracellular signaling mechanisms leading to vascular smooth muscle cell (VSMC) growth. It is therefore critical to define the potential enzymatic sources of ROS and their regulation by agonists in VSMCs. Previous studies have investigated O2*- production using lucigenin-enhanced chemiluminescence. However, lucigenin has been recently criticized for its ability to redox cycle and its propensity to measure cellular reductase activity independent from O2*-. To perform a definitive characterization of VSMC oxidase activity, we used electron spin resonance trapping of O2*- with DEPMPO. We confirmed that the main source of O2*- from VSMC membranes is an NAD(P)H oxidase and that the O2*- formation from mitochondria, xanthine oxidase, arachidonate-derived enzymes, and nitric oxide synthases in VSMC membranes was minor. The VSMC NAD(P)H oxidase(s) are able to produce more O2*- when NADPH is used as the substrate compared to NADH (the maximal NADPH signal is 2.4- +/- 0.4-fold higher than the NADH signal). The two substrates had similar EC(50)'s ( approximately 10-50 microM). Stimulation with angiotensin II and platelet-derived growth factor also predominantly increased the NADPH-driven signal (101 +/- 8% and 83 +/- 1% increase above control, respectively), with less of an effect on NADH-dependent O2*- (17 +/- 3% and 36 +/- 5% increase, respectively). Moreover, incubation of the cells with diphenylene iodonium inhibited predominantly NADPH-stimulated O2*-. In conclusion, electron spin resonance characterization of VSMC oxidase activity supports a major role for an NAD(P)H oxidase in O2*- production in VSMCs, and provides new evidence concerning the substrate dependency and agonist-stimulated activity of this key enzyme.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11295358     DOI: 10.1016/s0891-5849(00)00507-4

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  23 in total

1.  Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia.

Authors:  X-L Cui; D Brockman; B Campos; L Myatt
Journal:  Placenta       Date:  2005-07-01       Impact factor: 3.481

2.  NADPH oxidase is required for NMDA receptor-dependent activation of ERK in hippocampal area CA1.

Authors:  Kenneth T Kishida; Maryland Pao; Steven M Holland; Eric Klann
Journal:  J Neurochem       Date:  2005-07       Impact factor: 5.372

3.  Disruption of SM22 promotes inflammation after artery injury via nuclear factor kappaB activation.

Authors:  Jianbin Shen; Maozhou Yang; Donghong Ju; Hong Jiang; Jian-Pu Zheng; Zhonghui Xu; Li Li
Journal:  Circ Res       Date:  2010-03-11       Impact factor: 17.367

Review 4.  Vascular dysfunction in retinopathy-an emerging role for arginase.

Authors:  Ruth B Caldwell; Wenbo Zhang; Maritza J Romero; R William Caldwell
Journal:  Brain Res Bull       Date:  2009-09-06       Impact factor: 4.077

5.  Hypoxia-inducible factor-1 activation in nonhypoxic conditions: the essential role of mitochondrial-derived reactive oxygen species.

Authors:  David A Patten; Véronique N Lafleur; Geneviève A Robitaille; Denise A Chan; Amato J Giaccia; Darren E Richard
Journal:  Mol Biol Cell       Date:  2010-07-21       Impact factor: 4.138

6.  Impaired nitric oxide-mediated flow-induced coronary dilation in hyperhomocysteinemia: morphological and functional evidence for increased peroxynitrite formation.

Authors:  Zoltan Ungvari; Anna Csiszar; Zsolt Bagi; Akos Koller
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

7.  Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production.

Authors:  Sergey I Dikalov; Anna E Dikalova; Alfiya T Bikineyeva; Harald H H W Schmidt; David G Harrison; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2008-08-16       Impact factor: 7.376

8.  Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells.

Authors:  Alicia N Lyle; Nita N Deshpande; Yoshihiro Taniyama; Bonnie Seidel-Rogol; Lily Pounkova; Pingfeng Du; Christopher Papaharalambus; Bernard Lassègue; Kathy K Griendling
Journal:  Circ Res       Date:  2009-07-02       Impact factor: 17.367

Review 9.  Role of oxidative stress and nitric oxide in atherothrombosis.

Authors:  Edith Lubos; Diane E Handy; Joseph Loscalzo
Journal:  Front Biosci       Date:  2008-05-01

10.  The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db/db mice.

Authors:  Mitsuhisa Koga; Niels Engberding; Anna E Dikalova; Kyung Hwa Chang; Bonnie Seidel-Rogol; James S Long; Bernard Lassègue; Hanjoong Jo; Kathy K Griendling
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-28       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.